OPC Pharmaceutical JSC (HOSE:OPC)

OPC Pharmaceutical JSC Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	968,576	1,004,887	1,171,614	1,123,728	965,591
Revenue Growth (YoY)	-3.61%	-14.23%	4.26%	16.38%	-2.40%
Cost of Revenue	522,458	526,456	637,906	643,499	572,130
Gross Profit	446,118	478,431	533,708	480,229	393,460
Selling, General & Admin	311,684	332,311	355,073	313,516	257,049
Operating Expenses	311,684	332,311	355,073	313,516	257,049
Operating Income	134,434	146,120	178,636	166,713	136,411
Interest Expense	-	-334.55	-925.2	-4,819	-5,490
Interest & Investment Income	8,335	15,854	7,813	3,707	4,391
Earnings From Equity Investments	1,535	838.45	797.74	172.88	1,877
Currency Exchange Gain (Loss)	448.73	555.41	279.37	360.84	622.41
Other Non Operating Income (Expenses)	-7,627	-7,710	-6,677	-6,894	-5,034
EBT Excluding Unusual Items	137,126	155,323	179,924	159,241	132,778
Pretax Income	137,126	155,323	179,924	159,241	132,778
Income Tax Expense	27,672	33,004	37,530	35,878	29,871
Earnings From Continuing Operations	109,454	122,319	142,394	123,363	102,907
Minority Interest in Earnings	-2,394	-84.74	-266.22	3,014	2,884
Net Income	107,060	122,234	142,128	126,377	105,791
Preferred Dividends & Other Adjustments	16,059	18,677	14,010	13,416	10,993
Net Income to Common	91,001	103,557	128,118	112,961	94,798
Net Income Growth	-12.41%	-14.00%	12.46%	19.46%	4.81%
Shares Outstanding (Basic)	64	64	64	64	64
Shares Outstanding (Diluted)	64	64	64	64	64
Shares Change (YoY)	-	-	-	-0.00%	-
EPS (Basic)	1420.76	1616.80	2000.25	1763.61	1480.03
EPS (Diluted)	1420.76	1616.80	2000.00	1763.61	1480.03
EPS Growth	-12.13%	-19.16%	13.40%	19.16%	4.88%
Free Cash Flow	12,147	243,317	28,688	181,809	93,340
Free Cash Flow Per Share	189.65	3798.80	447.90	2838.51	1457.27
Dividend Per Share	-	1500.000	1500.000	-	1244.813
Gross Margin	46.06%	47.61%	45.55%	42.73%	40.75%
Operating Margin	13.88%	14.54%	15.25%	14.84%	14.13%
Profit Margin	9.40%	10.30%	10.94%	10.05%	9.82%
Free Cash Flow Margin	1.25%	24.21%	2.45%	16.18%	9.67%
EBITDA	156,652	169,015	201,454	189,215	158,152
EBITDA Margin	16.17%	16.82%	17.20%	16.84%	16.38%
D&A For EBITDA	22,218	22,895	22,819	22,502	21,740
EBIT	134,434	146,120	178,636	166,713	136,411
EBIT Margin	13.88%	14.54%	15.25%	14.84%	14.13%
Effective Tax Rate	20.18%	21.25%	20.86%	22.53%	22.50%
Revenue as Reported	968,576	1,004,887	1,171,614	1,123,728	965,591
Advertising Expenses	43,302	51,343	48,858	40,148	17,880

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.